Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Epidemiology and prognosis of candidaemia in elderly patients.

Ramos-Martínez A, Vicente-López N, Sánchez-Romero I, Padilla B, Merino-Amador P, Garnacho-Montero J, Ruiz-Camps I, Montejo M, Salavert M, Mensa J, Cuenca-Estrella M; Members of the CANDIPOP Project from GEIH-GEMICOMED (SEIMC) and REIPI.

Mycoses. 2017 Dec;60(12):808-817. doi: 10.1111/myc.12677. Epub 2017 Aug 23.

PMID:
28836309
2.

Clinical presentation of candidaemia in elderly patients: experience in a single institution.

Lerma A, Cantero E, Soriano M, Orden B, Muñez E, Ramos-Martinez A.

Rev Esp Quimioter. 2017 Jun;30(3):207-212. Epub 2017 Mar 31.

3.

Epidemiology and management of candidaemia--a retrospective, multicentre study in five hospitals in the UK.

Chalmers C, Gaur S, Chew J, Wright T, Kumar A, Mathur S, Wan WY, Gould IM, Leanord A, Bal AM.

Mycoses. 2011 Nov;54(6):e795-800. doi: 10.1111/j.1439-0507.2011.02027.x. Epub 2011 May 25.

PMID:
21615542
4.

Epidemiology, species distribution, clinical characteristics and mortality of candidaemia in a tertiary care university hospital in Turkey, 2007-2014.

Yeşilkaya A, Azap Ö, Aydın M, Akçil Ok M.

Mycoses. 2017 Jul;60(7):433-439. doi: 10.1111/myc.12618. Epub 2017 Mar 24.

PMID:
28338249
5.

Epidemiology and outcome of candidaemia in patients with oncological and haematological malignancies: results from a population-based surveillance in Spain.

Puig-Asensio M, Ruiz-Camps I, Fernández-Ruiz M, Aguado JM, Muñoz P, Valerio M, Delgado-Iribarren A, Merino P, Bereciartua E, Fortún J, Cuenca-Estrella M, Almirante B; CANDIPOP Project,; GEIH-GEMICOMED SEIMC; REIPI.

Clin Microbiol Infect. 2015 May;21(5):491.e1-10. doi: 10.1016/j.cmi.2014.12.027. Epub 2015 Jan 14.

6.

A prospective, cohort, multicentre study of candidaemia in hospitalized adult patients with haematological malignancies.

Gamaletsou MN, Walsh TJ, Zaoutis T, Pagoni M, Kotsopoulou M, Voulgarelis M, Panayiotidis P, Vassilakopoulos T, Angelopoulou MK, Marangos M, Spyridonidis A, Kofteridis D, Pouli A, Sotiropoulos D, Matsouka P, Argyropoulou A, Perloretzou S, Leckerman K, Manaka A, Oikonomopoulos P, Daikos G, Petrikkos G, Sipsas NV.

Clin Microbiol Infect. 2014 Jan;20(1):O50-7. doi: 10.1111/1469-0691.12312. Epub 2013 Jul 24.

7.

Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain.

Puig-Asensio M, Padilla B, Garnacho-Montero J, Zaragoza O, Aguado JM, Zaragoza R, Montejo M, Muñoz P, Ruiz-Camps I, Cuenca-Estrella M, Almirante B; CANDIPOP Project; GEIH-GEMICOMED (SEIMC); REIPI.

Clin Microbiol Infect. 2014 Apr;20(4):O245-54. doi: 10.1111/1469-0691.12380. Epub 2013 Oct 11.

8.

Breakthrough candidaemia in the era of broad-spectrum antifungal therapies.

Cuervo G, Garcia-Vidal C, Nucci M, Puchades F, Fernández-Ruiz M, Obed M, Manzur A, Gudiol C, Pemán J, Aguado JM, Ayats J, Carratalà J.

Clin Microbiol Infect. 2016 Feb;22(2):181-188. doi: 10.1016/j.cmi.2015.09.029. Epub 2015 Oct 13.

9.

Candidaemia in a paediatric centre and importance of central venous catheter removal.

Karadag-Oncel E, Kara A, Ozsurekci Y, Arikan-Akdagli S, Cengiz AB, Ceyhan M, Gur D, Celik M, Ozkaya-Parlakay A.

Mycoses. 2015 Mar;58(3):140-8. doi: 10.1111/myc.12288. Epub 2015 Feb 10.

PMID:
25678411
10.

Risk factors, clinical presentation and prognosis of mixed candidaemia: a population-based surveillance in Spain.

Ramos A, Romero Y, Sánchez-Romero I, Fortún J, Paño JR, Pemán J, Gurguí M, Rodríguez-Baño J, Padilla B.

Mycoses. 2016 Oct;59(10):636-43. doi: 10.1111/myc.12516. Epub 2016 Jul 21.

PMID:
27440082
11.

Molecular epidemiology of late recurrent candidaemia--a population-based study in Iceland.

Asmundsdóttir LR, Erlendsdóttir H, Gísladóttir AL, Gottfredsson M.

Clin Microbiol Infect. 2012 Feb;18(2):195-201. doi: 10.1111/j.1469-0691.2011.03595.x. Epub 2011 Jul 7.

12.

Impact of therapeutic strategies on the prognosis of candidemia in the ICU.

Puig-Asensio M, Pemán J, Zaragoza R, Garnacho-Montero J, Martín-Mazuelos E, Cuenca-Estrella M, Almirante B; Prospective Population Study on Candidemia in Spain (CANDIPOP) Project; Hospital Infection Study Group (GEIH); Medical Mycology Study Group (GEMICOMED) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC); Spanish Network for Research in Infectious Diseases.

Crit Care Med. 2014 Jun;42(6):1423-32. doi: 10.1097/CCM.0000000000000221.

PMID:
24557426
13.

Clinical characteristics and treatment outcomes of patients with candidaemia due to Candida parapsilosis sensu lato species at a medical centre in Taiwan, 2000-12.

Chen CY, Sheng WH, Huang SY, Chou WC, Yao M, Tang JL, Tsay W, Tien HF, Hsueh PR.

J Antimicrob Chemother. 2015 May;70(5):1531-8. doi: 10.1093/jac/dku540. Epub 2015 Jan 3.

PMID:
25558079
14.

Clinical characteristics of candidaemia in adults with haematological malignancy, and antimicrobial susceptibilities of the isolates at a medical centre in Taiwan, 2001-2010.

Chen CY, Huang SY, Tsay W, Yao M, Tang JL, Ko BS, Chou WC, Tien HF, Hsueh PR.

Int J Antimicrob Agents. 2012 Dec;40(6):533-8. doi: 10.1016/j.ijantimicag.2012.07.022. Epub 2012 Sep 21.

PMID:
23006521
15.

Epidemiology and reporting of candidaemia in Belgium: a multi-centre study.

Trouvé C, Blot S, Hayette MP, Jonckheere S, Patteet S, Rodriguez-Villalobos H, Symoens F, Van Wijngaerden E, Lagrou K.

Eur J Clin Microbiol Infect Dis. 2017 Apr;36(4):649-655. doi: 10.1007/s10096-016-2841-3. Epub 2016 Nov 17.

PMID:
27858242
16.

Candida species bloodstream infection: epidemiology and outcome in a single institution from 1991 to 2008.

Ortega M, Marco F, Soriano A, Almela M, Martínez JA, López J, Pitart C, Mensa J.

J Hosp Infect. 2011 Feb;77(2):157-61. doi: 10.1016/j.jhin.2010.09.026. Epub 2011 Jan 7.

PMID:
21216030
17.

Impact on hospital mortality of catheter removal and adequate antifungal therapy in Candida spp. bloodstream infections.

Garnacho-Montero J, Díaz-Martín A, García-Cabrera E, Ruiz Pérez de Pipaón M, Hernández-Caballero C, Lepe-Jiménez JA.

J Antimicrob Chemother. 2013 Jan;68(1):206-13. doi: 10.1093/jac/dks347. Epub 2012 Sep 3.

PMID:
22945914
18.

Candida and candidaemia. Susceptibility and epidemiology.

Arendrup MC.

Dan Med J. 2013 Nov;60(11):B4698. Review.

PMID:
24192246
19.

Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemia.

Cantón E, Pemán J, Quindós G, Eraso E, Miranda-Zapico I, Álvarez M, Merino P, Campos-Herrero I, Marco F, de la Pedrosa EG, Yagüe G, Guna R, Rubio C, Miranda C, Pazos C, Velasco D; FUNGEMYCA Study Group.

Antimicrob Agents Chemother. 2011 Dec;55(12):5590-6. doi: 10.1128/AAC.00466-11. Epub 2011 Sep 19.

20.

[Age group, geographical incidence and patterns of antifungal susceptibility of Candida species causing candidemia in the Spanish paediatric population].

García-Rodríguez J, Cantón E, Pemán J, Alvarez M, Ezpeleta G, Gómez-Nieto A, Iglesias I, Martín-Mazuelos E, Ramírez-de Ocariz I, Rezusta A, Royo-García G; Grupo de Estudio FUNGEMYCA.

Enferm Infecc Microbiol Clin. 2013 Jun-Jul;31(6):363-8. doi: 10.1016/j.eimc.2012.09.018. Epub 2013 Feb 8. Spanish.

PMID:
23398860

Supplemental Content

Support Center